MDM2 and hepatocellular carcinoma: Since MDM2 is overexpressed in HCC, we try to evaluate whether the MDM2 protein is a potential TAA in HCC and validate if autoantibody to this protein can be used as an early stage biomarker in immunodiagnosis of HCC.